SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-010806
Filing Date
2024-03-21
Accepted
2024-03-21 17:07:34
Documents
16
Period of Report
2024-03-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 81078
2 ex3-1.htm EX-3.1 87684
3 ex3-2.htm EX-3.2 50762
  Complete submission text file 0001493152-24-010806.txt   476627

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE tvgn-20240315.xsd EX-101.SCH 3815
5 XBRL DEFINITION FILE tvgn-20240315_def.xml EX-101.DEF 27133
6 XBRL LABEL FILE tvgn-20240315_lab.xml EX-101.LAB 37520
7 XBRL PRESENTATION FILE tvgn-20240315_pre.xml EX-101.PRE 25754
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6171
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41002 | Film No.: 24772225
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)